Losartan News and Research

RSS
Losartan is a drug used to treat high blood pressure. Losartan blocks the action of chemicals that make blood vessels constrict (get narrower). It is a type of angiotensin II receptor antagonist. Also called Cozaar and losartan potassium.
Benicar better than Cozaar in reducing blood pressure: Study

Benicar better than Cozaar in reducing blood pressure: Study

Tracking heart rate can provide important marker of health issues: Research

Tracking heart rate can provide important marker of health issues: Research

Merck reports strong bottom-line performance in second quarter

Merck reports strong bottom-line performance in second quarter

Teva second-quarter net sales increase 12% to $3.8 billion

Teva second-quarter net sales increase 12% to $3.8 billion

Proteinuria screening identifies risk for kidney disease progression

Proteinuria screening identifies risk for kidney disease progression

ARBs may be linked with increased risk of developing cancer: US scientists

ARBs may be linked with increased risk of developing cancer: US scientists

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

Merck reports non-GAAP EPS of $0.83 for first-quarter 2010

FDA approves Mylan Pharmaceuticals' ANDA for generic Hyzaar

FDA approves Mylan Pharmaceuticals' ANDA for generic Hyzaar

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

Generic Hyzaar and Cozaar litigation: Court of Appeals rules in favor of Teva Pharmaceutical Industries

Generic Hyzaar and Cozaar litigation: Court of Appeals rules in favor of Teva Pharmaceutical Industries

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Short-term dose of losartan-M6PHSA reduces liver inflammation and fibrosis: Study

Merck announces global sales of $27.4 billion for full-year 2009

Merck announces global sales of $27.4 billion for full-year 2009

China Pharma Holdings announces completion of clinical trials for Candesartan

China Pharma Holdings announces completion of clinical trials for Candesartan

Study: Larger dose of ARBs is more effective in heart failure patients

Study: Larger dose of ARBs is more effective in heart failure patients

Merck's sales increases by 2% in third quarter 2009

Merck's sales increases by 2% in third quarter 2009

Findings may yield new treatments for COPD

Findings may yield new treatments for COPD

Blood pressure drug reverses liver damage

Blood pressure drug reverses liver damage

Blood-pressure medicine shown to reverse the effects of early-stage liver failure

Blood-pressure medicine shown to reverse the effects of early-stage liver failure

Blood pressure drug losartan may benefit brain tumor patients

Blood pressure drug losartan may benefit brain tumor patients

Researchers devise means to create blood by discovering earliest form of human blood stem cells

Researchers devise means to create blood by discovering earliest form of human blood stem cells